Cargando…
CRISPR/Cas9 in Gastrointestinal Malignancies
Gastrointestinal (GI) cancers such as colorectal cancer (CRC), gastric cancer (GC), esophageal cancer (EG), pancreatic duct adenocarcinoma (PDAC) or hepatocellular cancer (HCC) belong to the most commonly diagnosed types of cancer and are among the most frequent causes of cancer related death worldw...
Autores principales: | Jefremow, André, Neurath, Markus F., Waldner, Maximilian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667614/ https://www.ncbi.nlm.nih.gov/pubmed/34912798 http://dx.doi.org/10.3389/fcell.2021.727217 |
Ejemplares similares
-
CRISPR Cas9 in Pancreatic Cancer Research
por: Yang, Hai, et al.
Publicado: (2019) -
Opportunities for CRISPR/Cas9 Gene Editing in Retinal Regeneration Research
por: Campbell, Leah J., et al.
Publicado: (2017) -
Breakage of CRISPR/Cas9-Induced Chromosome Bridges in Mitotic Cells
por: Rodriguez-Muñoz, Marina, et al.
Publicado: (2021) -
Application of CRISPR/Cas9 System in Establishing Large Animal Models
por: Lin, Yingqi, et al.
Publicado: (2022) -
Multiplexed CRISPR/Cas9 Targeting of Genes Implicated in Retinal Regeneration and Degeneration
por: Unal Eroglu, Arife, et al.
Publicado: (2018)